p.R130C | TCGA-2G-AAFE | TGCT | TCGA | LQRGRLSR | SCF_FBXL2 | 120:127 | Mutation rewiring degron network | 0.25 |
p.R130C | DO230326 | COCA | ICGC | LQRGRLSR | SCF_FBXL2 | 120:127 | Mutation rewiring degron network | 0.25 |
p.N118D | DO234362 | ESAD | ICGC | LQRGRLSR | SCF_FBXL2 | 120:127 | Mutation rewiring degron network | 0.2778 |
p.E128K | DO228261 | LICA | ICGC | LQRGRLSR | SCF_FBXL2 | 120:127 | Mutation rewiring degron network | 0.3056 |
p.E128K | DO42472 | UCEC | ICGC | LQRGRLSR | SCF_FBXL2 | 120:127 | Mutation rewiring degron network | 0.3056 |
p.N130K | DO228948 | LICA | ICGC | LQRGRLSR | SCF_FBXL2 | 120:127 | Mutation rewiring degron network | 0.25 |
p.T136N | DO229026 | LICA | ICGC | LQRGRLSR | SCF_FBXL2 | 120:127 | Mutation rewiring degron network | 0.0833 |
p.H135Q | DO229009 | LICA | ICGC | LQRGRLSR | SCF_FBXL2 | 120:127 | Mutation rewiring degron network | 0.1111 |
p.S116I | DO49657 | LIHC | ICGC | LQRGRLSR | SCF_FBXL2 | 120:127 | Mutation rewiring degron network | 0.2222 |
p.R127P | DO229085 | THCA | ICGC | LQRGRLSR | SCF_FBXL2 | 120:127 | Mutation altering degron motif | 0.6401 |
p.P115L | DO42480 | UCEC | ICGC | LQRGRLSR | SCF_FBXL2 | 120:127 | Mutation rewiring degron network | 0.1944 |
p.G111R | SIDM00454 | Rhabdomyosarcoma | GDSC | LQRGRLSR | SCF_FBXL2 | 120:127 | Mutation rewiring degron network | 0.0833 |
p.G111R | SIDM00087 | Plasma Cell Myeloma | GDSC | LQRGRLSR | SCF_FBXL2 | 120:127 | Mutation rewiring degron network | 0.0833 |
p.G111R | SIDM00633 | Breast Carcinoma | GDSC | LQRGRLSR | SCF_FBXL2 | 120:127 | Mutation rewiring degron network | 0.0833 |
p.G111R | SIDM00654 | Small Cell Lung Carcinoma | GDSC | LQRGRLSR | SCF_FBXL2 | 120:127 | Mutation rewiring degron network | 0.0833 |
p.G111R | SIDM01112 | Osteosarcoma | GDSC | LQRGRLSR | SCF_FBXL2 | 120:127 | Mutation rewiring degron network | 0.0833 |
p.G111R | SIDM00052 | Esophageal Squamous Cell Carcinoma | GDSC | LQRGRLSR | SCF_FBXL2 | 120:127 | Mutation rewiring degron network | 0.0833 |
p.G111R | SIDM00309 | Mesothelioma | GDSC | LQRGRLSR | SCF_FBXL2 | 120:127 | Mutation rewiring degron network | 0.0833 |
p.G111R | SIDM00032 | Bladder Carcinoma | GDSC | LQRGRLSR | SCF_FBXL2 | 120:127 | Mutation rewiring degron network | 0.0833 |
p.G111R | SIDM00720 | Mesothelioma | GDSC | LQRGRLSR | SCF_FBXL2 | 120:127 | Mutation rewiring degron network | 0.0833 |
p.G111R | SIDM00760 | Small Cell Lung Carcinoma | GDSC | LQRGRLSR | SCF_FBXL2 | 120:127 | Mutation rewiring degron network | 0.0833 |
p.G111R | SIDM01686 | Chronic Myelogenous Leukemia | GDSC | LQRGRLSR | SCF_FBXL2 | 120:127 | Mutation rewiring degron network | 0.0833 |
p.G111R | SIDM01710 | Squamous Cell Lung Carcinoma | GDSC | LQRGRLSR | SCF_FBXL2 | 120:127 | Mutation rewiring degron network | 0.0833 |
p.A135V | SIDM01007 | T-Lymphoblastic Leukemia | GDSC | LQRGRLSR | SCF_FBXL2 | 120:127 | Mutation rewiring degron network | 0.1111 |
p.E112K | SIDM00417 | Plasma Cell Myeloma | GDSC | LQRGRLSR | SCF_FBXL2 | 120:127 | Mutation rewiring degron network | 0.1111 |
p.E112K | U-266 | haematopoietic and lymphoid tissue | COSMIC | LQRGRLSR | SCF_FBXL2 | 120:127 | Mutation rewiring degron network | 0.1111 |
p.G137D | SIDM00854 | Burkitt's Lymphoma | GDSC | LQRGRLSR | SCF_FBXL2 | 120:127 | Mutation rewiring degron network | 0.0556 |
p.G137D | ACH-000162 | Lymphoma | CCLE | LQRGRLSR | SCF_FBXL2 | 120:127 | Mutation rewiring degron network | 0.0556 |
p.P133L | SIDM00381 | Cervical Carcinoma | GDSC | LQRGRLSR | SCF_FBXL2 | 120:127 | Mutation rewiring degron network | 0.1667 |
p.P133L | SIDM00500 | Colorectal Carcinoma | GDSC | LQRGRLSR | SCF_FBXL2 | 120:127 | Mutation rewiring degron network | 0.1667 |
p.L120P | ACH-000895 | Colon/Colorectal Cancer | CCLE | LQRGRLSR | SCF_FBXL2 | 120:127 | Mutation altering degron motif | 0.7582 |
p.L120P | CL-34 | large intestine | COSMIC | LQRGRLSR | SCF_FBXL2 | 120:127 | Mutation altering degron motif | 0.7582 |